296 related articles for article (PubMed ID: 25280033)
21. Ataxia-telangiectasia or Louis-Bar syndrome.
Smith LL; Conerly SL
J Am Acad Dermatol; 1985 Apr; 12(4):681-96. PubMed ID: 2580869
[TBL] [Abstract][Full Text] [Related]
22. Unusual absence of neurologic symptoms in a six-year old girl with ataxia-telangiectasia.
Trimis GG; Athanassaki CK; Kanariou MM; Giannoulia-Karantana AA
J Postgrad Med; 2004; 50(4):270-1. PubMed ID: 15623968
[TBL] [Abstract][Full Text] [Related]
23. Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia.
Zielen S; Duecker RP; Woelke S; Donath H; Bakhtiar S; Buecker A; Kreyenberg H; Huenecke S; Bader P; Mahlaoui N; Ehl S; El-Helou SM; Pietrucha B; Plebani A; van der Flier M; van Aerde K; Kilic SS; Reda SM; Kostyuchenko L; McDermott E; Galal N; Pignata C; Pérez JLS; Laws HJ; Niehues T; Kutukculer N; Seidel MG; Marques L; Ciznar P; Edgar JDM; Soler-Palacín P; von Bernuth H; Krueger R; Meyts I; Baumann U; Kanariou M; Grimbacher B; Hauck F; Graf D; Granado LIG; Prader S; Reisli I; Slatter M; Rodríguez-Gallego C; Arkwright PD; Bethune C; Deripapa E; Sharapova SO; Lehmberg K; Davies EG; Schuetz C; Kindle G; Schubert R
J Clin Immunol; 2021 Nov; 41(8):1878-1892. PubMed ID: 34477998
[TBL] [Abstract][Full Text] [Related]
24. [Ataxia-telangiectasia syndrome. Clinical and diagnostic aspects].
Diaconu G; Grigore I; Moisă SM; Burlea M
Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):386-90. PubMed ID: 17983173
[TBL] [Abstract][Full Text] [Related]
25. Ataxia-telangiectasia, an evolving phenotype.
Chun HH; Gatti RA
DNA Repair (Amst); 2004; 3(8-9):1187-96. PubMed ID: 15279807
[TBL] [Abstract][Full Text] [Related]
26. Cerebral white-matter changes suggesting leukodystrophy in ataxia telangiectasia.
Chung EO; Bodensteiner JB; Noorani PA; Schochet SS
J Child Neurol; 1994 Jan; 9(1):31-5. PubMed ID: 7512106
[TBL] [Abstract][Full Text] [Related]
27. Variants of Nijmegen breakage syndrome and ataxia telangiectasia.
Weemaes CM; Smeets DF; Horstink M; Haraldsson A; Bakkeren JA
Immunodeficiency; 1993; 4(1-4):109-11. PubMed ID: 7513225
[TBL] [Abstract][Full Text] [Related]
28. Ataxia-telangiectasia: Immunodeficiency and survival.
van Os NJH; Jansen AFM; van Deuren M; Haraldsson A; van Driel NTM; Etzioni A; van der Flier M; Haaxma CA; Morio T; Rawat A; Schoenaker MHD; Soresina A; Taylor AMR; van de Warrenburg BPC; Weemaes CMR; Roeleveld N; Willemsen MAAP
Clin Immunol; 2017 May; 178():45-55. PubMed ID: 28126470
[TBL] [Abstract][Full Text] [Related]
29. Ataxia telangiectasia: a review.
Rothblum-Oviatt C; Wright J; Lefton-Greif MA; McGrath-Morrow SA; Crawford TO; Lederman HM
Orphanet J Rare Dis; 2016 Nov; 11(1):159. PubMed ID: 27884168
[TBL] [Abstract][Full Text] [Related]
30. Different clinical and laboratory evolutions in ataxia-telangiectasia syndrome: report of four cases.
Forte WC; Menezes MC; Dionigi PC; Bastos CL
Allergol Immunopathol (Madr); 2005; 33(4):199-203. PubMed ID: 16045857
[TBL] [Abstract][Full Text] [Related]
31. Twenty-year follow-up of 160 patients with ataxia-telangiectasia.
Ersoy F; Berkel AI; Sanal O; Oktay H
Turk J Pediatr; 1991; 33(4):205-15. PubMed ID: 1814037
[TBL] [Abstract][Full Text] [Related]
32. Ataxia-telangiectasia: a clinical and laboratory review study of 14 cases.
Schwartzman JS; Solé D; Naspitz CK
Allergol Immunopathol (Madr); 1990; 18(2):105-11. PubMed ID: 1695474
[TBL] [Abstract][Full Text] [Related]
33. Ataxia telangiectasia.
Nissenkorn A; Ben-Zeev B
Handb Clin Neurol; 2015; 132():199-214. PubMed ID: 26564081
[TBL] [Abstract][Full Text] [Related]
34. A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas.
Minto H; Mensah KA; Reynolds PR; Meffre E; Rubtsova K; Gelfand EW
Clin Immunol; 2019 Mar; 200():55-63. PubMed ID: 30639167
[TBL] [Abstract][Full Text] [Related]
35. [Pathogenesis, diagnosis, clinical and therapeutic aspects of ataxia telangiectasia].
Güngör T; Bühring I; Cremer R; Gartenschläger M; Zielen S
Klin Padiatr; 1997; 209(5):328-35. PubMed ID: 9411043
[TBL] [Abstract][Full Text] [Related]
36. Telangiectasias in Ataxia Telangiectasia: Clinical significance, role of ATM deficiency and potential pathophysiological mechanisms.
Schoenaker MHD; Van Os NJH; Van der Flier M; Van Deuren M; Seyger MM; Taylor AMR; Weemaes CMR; Willemsen MAAP
Eur J Med Genet; 2018 May; 61(5):284-287. PubMed ID: 29288088
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation in
Algahtani H; Shirah B; Algahtani R; Al-Qahtani MH; Abdulkareem AA; Naseer MI
Int J Neurosci; 2021 Feb; 131(2):206-211. PubMed ID: 32172615
[TBL] [Abstract][Full Text] [Related]
38. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients.
Amirifar P; Mozdarani H; Yazdani R; Kiaei F; Moeini Shad T; Shahkarami S; Abolhassani H; Delavari S; Sohani M; Rezaei A; Hassanpour G; Akrami SM; Aghamohammadi A
Immunol Invest; 2021 Feb; 50(2-3):201-215. PubMed ID: 32116070
[No Abstract] [Full Text] [Related]
39. The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.
Stray-Pedersen A; Jónsson T; Heiberg A; Lindman CR; Widing E; Aaberge IS; Borresen-Dale AL; Abrahamsen TG
Clin Exp Immunol; 2004 Jul; 137(1):179-86. PubMed ID: 15196260
[TBL] [Abstract][Full Text] [Related]
40. Identification of ATM mutations in Korean siblings with ataxia-telangiectasia.
Huh HJ; Cho KH; Lee JE; Kwon MJ; Ki CS; Lee PH
Ann Lab Med; 2013 May; 33(3):217-20. PubMed ID: 23667852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
